BAROnova brings in $36.5M Series D for implanted weight-loss device
BAROnova has brought in significant capital to fund its U.S. clinical study of its endoscopically delivered weight-loss device, the TransPyloric Shuttle (TPS).
View ArticleClik here to view.
Livongo’s latest acquisition adds personalized weight management, diabetes...
The deal will give Livongo the ability to provide a wider spectrum of services for employer wellness and health plan members.
View ArticleClik here to view.
Obesity is a disease—and it’s treatable
Obesity is a disease, and America’s healthcare providers and hospital systems must be part of changing how we treat it. That means many of us in the health ecosystem must reexamine how we view patients...
View ArticleClik here to view.
WeightWatchers To Acquire Chronic Weight Management Digital Health Platform
WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription...
View ArticleClik here to view.
Found Launches Employer-focused Obesity Care Program
Found for Business is an evidence-based obesity care program that prescribes 13 different medications (including GLP-1s) in 60 different combinations. It combines the medication with support from...
View ArticleClik here to view.
LifeMD Launches GLP-1 Weight Management Program
Through LifeMD’s new weight management program, consumers can gain access to GLP-1 prescriptions like Ozempic and Wegovy, clinical support, lab testing, education and more.
View ArticleClik here to view.
Alfie Health Raises $2.1M for AI-powered Weight Loss Platform
Alfie Health’s $2.1 million seed funding was led by Y Combinator and Nina Capital. It included participation from Goodwater Capital, Phoenix Investment Club and several angel investors.
View ArticleClik here to view.
Hello Alpha Unveils Female-focused Weight Management Program for Employers
Hello Alpha launched Ahead with Alpha, a weight management program for employers. It offers access to primary care providers trained in obesity care, medication management through weight loss drugs...
View ArticleClik here to view.
Solera Health Launches Weight Management Solution for Payers and Employers
Solera Health recently launched a program that aims to help patients who are interested in GLP-1s gain access to lifestyle change support. It also provides educational materials on GLP-1s.
View ArticleClik here to view.
Noom Offers Clinical Obesity Management Platform to Employers
Noom is now offering Noom Med to employers. The program is intended for patients who need more clinical support in their weight loss journey. It offers access to a clinician and medications, including...
View ArticleClik here to view.
Carmot’s IPO Filing Makes Case for Bias in Drugging Key Obesity, Diabetes...
Carmot Therapeutics isn’t the first company targeting both the GLP-1 and GIP receptors to treat metabolic diseases. But the company contends that biased signaling—activating certain pathways but not...
View ArticleClik here to view.
WeightWatchers Launches New GLP-1 Support Program
WeightWatchers’ new GLP-1 program offers daily nutritional and activity targets, recommended foods, recipes, food and activity tracking, a digital community, virtual workshops and access to coaches...
View ArticleClik here to view.
The Prohibitive Economics of Weight Care
How we discuss overweight and obese diagnoses and how we treat those patients is slowly starting to improve. However, there’s still a lot of work to be done – in how we manufacture, market, and manage...
View ArticleClik here to view.
Novo Holdings Bolsters GLP-1 Production Capacity With $16.5B Catalent Buyout
After Novo Holdings acquires Catalent, it will sell three of the contract manufacturing giant’s sites to Novo Nordisk. Those facilities already make Novo Nordisk’s GLP-1 drugs for metabolic conditions,...
View ArticleClik here to view.
Lower BMI, Raise ROI: How Physician Practices Can Boost Revenues with Turnkey...
The webinar, scheduled for March 6 at 2pm ET and sponsored by Build My Health, will discuss several topics related to weight management including: an overview of GLP-1 weight loss medication,...
View ArticleClik here to view.
Downside of One-Size-Fits-All: Rethinking Weight-Loss Medications Strategy
A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.
View ArticleClik here to view.
Omada Expands GLP-1 Care Track To Include Exercise Plans, Member Level Reporting
Omada’s newly expanded GLP-1 Care Track provides tailored exercise plans, support for getting off of GLP-1s and calorie tracking. It also offers insight into who is responding to GLP-1s and who is...
View ArticleClik here to view.
Let’s Make This the Last World Obesity Care Week
By eliminating the term “obesity” in favor of person-centric language, we pave the way for a more equitable healthcare system that prioritizes the well-being of all individuals, regardless of their...
View ArticleClik here to view.
How to Help Physicians Generate More Revenue and Make Their Patients Healthier
Interest in using GLP-1 drugs to reduce obesity combined with a desire by physicians to become less dependent on insurance-based reimbursement after the recent Change Healthcare cyberattack is...
View Article
